Search Results 1-10 of 16503 for Tuberous sclerosis

  1. Tuberous sclerosis - Symptoms and causes - Mayo Clinic

    Tuberous sclerosis is a genetic disorder caused by gene changes — sometimes called mutations — in either the TSC1 or the TSC2 gene. These genes are thought to ...

  2. Tuberous sclerosis - Diagnosis and treatment - Mayo Clinic

    Tuberous sclerosis · Seizure evaluation. Diagnostic testing will likely include an electroencephalogram (eh-lek-tro-en-SEF-uh-lo-gram), sometimes called an EEG.

  3. Tuberous Sclerosis Clinic - Overview

    Mayo Clinic's Tuberous Sclerosis Clinic — composed of experts from neurology, medical genetics, genetic counseling, dermatology and nephrology — sees people ...

  4. Tuberous sclerosis - Doctors and departments - Mayo Clinic

    This uncommon genetic disorder causes tumors that are not cancer. These tumors are unexpected overgrowths of tissue in different parts of the body.

  5. Tuberous Sclerosis Clinical Trials

    Tuberous sclerosis. Displaying 3 studies. A Dose-Ranging Study to Evaluate the Effectiveness and Safety of Topical Rapamycin Cream for Facial Angiofibroma ...

  6. A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) - Mayo Clinic

    A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) · Overview · Participation eligibility.

  7. Tuberous sclerosis - Doctors and departments - Mayo Clinic

    This uncommon genetic disorder causes tumors that are not cancer. These tumors are unexpected overgrowths of tissue in different parts of the body.

  8. Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC) - Mayo Clinic

    Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC) · Overview · Participation ...

  9. A Dose-Ranging Study to Evaluate the Effectiveness and Safety of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex - Mayo Clinic

    A Dose-Ranging Study to Evaluate the Effectiveness and Safety of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex.

  10. Sirolimus (Topical Application Route) Description and Brand Names - Mayo Clinic

    Descriptions. Sirolimus topical gel is used to treat facial angiofibroma (type of noncancerous tumor) caused by a genetic condition called tuberous sclerosis.